Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
TTR-H5223 | Human | Human Transthyretin / Prealbumin Protein, His Tag |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Tafamidis Meglumine | FX-1006A; PF-6291826; Fx-1006A; PF-06291826 | Approved | Pfizer Inc | Vyndaqel, 维达全 | Mainland China | Amyloid Neuropathies | Pfizer Europe Ma Eeig | 2011-11-16 | Amyloid Neuropathies, Familial; Heart Diseases; Immunoglobulin Light-chain Amyloidosis; Cardiomyopathies; Amyloidosis; Amyloid Neuropathies; Transthyretin amyloidosis | Details |
Vutrisiran | ALN-TTRSC02 | Approved | Alnylam Pharmaceuticals Inc | AMVUTTRA | Japan | Transthyretin amyloidosis | Alnylam Japan Kk | 2022-06-13 | Amyloid Neuropathies, Familial; Amyloidosis, Familial; Cardiomyopathies; Amyloidosis; Transthyretin amyloidosis | Details |
Tafamidis | PF-6291826; Fx-1006A; PF-06291826; FX-1006A | Approved | Pfizer Inc | 维万心, VYNDAMAX | Mainland China | Transthyretin amyloidosis | Pfizer Europe Ma Eeig | 2019-05-03 | Heart Diseases; Transthyretin amyloidosis | Details |
Patisiran | SAR-438037; GENZ-438027; ALN-TTR02; ALN-18328 | Approved | Alnylam Pharmaceuticals Inc | Onpattro | Japan | Transthyretin amyloidosis | Alnylam Pharmaceuticals Inc | 2018-08-10 | Amyloidosis, Familial; Amyloid Neuropathies, Familial; Polyneuropathies; Cardiomyopathies; Amyloidosis; Transthyretin amyloidosis; Amyloid Neuropathies | Details |
Inotersen sodium | ISIS-420915; GSK-2998728 | Approved | Ionis Pharmaceuticals Inc | Tegsedi | United States | Transthyretin amyloidosis | Akcea Therapeutics Inc, Ptc Therapeutics Inc | 2018-07-05 | Adenomatous Polyposis Coli; Amyloid Neuropathies, Familial; Amyloidosis; Transthyretin amyloidosis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
NTLA-2001 | NTLA-2001 | Phase 1 Clinical | Regeneron Pharmaceuticals Inc, Intellia Therapeutics Inc | Amyloidosis, Familial; Cardiomyopathies; Transthyretin amyloidosis; Amyloid Neuropathies | Details |
NNC6019-0001 | NNC6019-0001; NNC-6019; PRX-004 | Phase 2 Clinical | Novo Nordisk A/S | Immunoglobulin Light-chain Amyloidosis; Cardiomyopathies | Details |
Eplontersen | ION-682884; ION-TTR-LRx; IONIS-TTR-LRx; AKCEA-TTR-LRx | Phase 3 Clinical | Ionis Pharmaceuticals Inc | Amyloid Neuropathies, Familial; Cardiomyopathies; Transthyretin amyloidosis | Details |
NI-006 | NI-006 | Phase 1 Clinical | Neurimmune Ag | Cardiomyopathies; Transthyretin amyloidosis | Details |
Acoramidis | AG-10; ALXN-2060; BBP-265 | Phase 3 Clinical | Stanford University, Bridgebio Pharma Inc | Amyloidosis, Familial; Heart Diseases; Cardiomyopathies; Amyloidosis; Transthyretin amyloidosis; Amyloid Neuropathies | Details |
This web search service is supported by Google Inc.